Endocannabinoid signaling pathways: beyond CB1R and CB2R

被引：21

作者：

Biringer, Roger Gregory ^{[1
]}

机构：

[1] Lake Erie Coll Osteopath Med, Coll Osteopath Med, Bradenton, FL 34211 USA

来源：

JOURNAL OF CELL COMMUNICATION AND SIGNALING | 2021年 / 15卷 / 03期

关键词：

Anandamide; 2-Acyl glycerol; Endocannabinoid; Phytocannabinoid; Cannabinoid; N-ARACHIDONOYL GLYCINE; COUPLED RECEPTOR 18; LYSOPHOSPHATIDIC ACID RECEPTOR; ROSTRAL VENTROLATERAL MEDULLA; GLUCAGON-LIKE PEPTIDE-1; CANNABINOID RECEPTORS; PANCREATIC BETA; HIGH-AFFINITY; CYCLIC-AMP; SPHINGOSINE; 1-PHOSPHATE;

D O I：

10.1007/s12079-021-00622-6

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

The search for cannabinoid receptors other than CB1R and CB2R has been ongoing for over a decade. A number of orphan receptors have been proposed as potential cannabinoid receptors primarily based on phylogenic arguments and reactivity towards known endocannabinoids and phytocannabinoids. Seven putative cannabinoid receptors are described and discussed, and evidence for and against their inclusion in this category are presented.

引用

页码：335 / 360

页数：26

共 50 条

[1] Endocannabinoid signaling pathways: beyond CB1R and CB2R
Roger Gregory Biringer
Journal of Cell Communication and Signaling, 2021, 15 : 335 - 360
[2] The Role of Endocannabinoid Receptor 1 (CB1R) in the Insulin Signaling Pathway
Kim, Yoo
Egan, Josephine M.
DIABETES, 2019, 68
[3] Differential Expression of Cannabinoid Receptors, CB1R and CB2R, in Prostate Tumor Samples with Perineural Invasion
Reyes, Tatiana M. Alicea
Flores-Otero, Jacqueline
FASEB JOURNAL, 2018, 32 (01):
[4] Involvement of CB1R and CB2R Ligands in Sleep Disorders and Addictive Behaviors in the Last 25 Years
Perez-Morales, Marcel
Espinoza-Abad, Rodolfo
Garcia-Garcia, Fabio
PHARMACEUTICALS, 2025, 18 (02)
[5] Positive Allosteric Modulation of CB1 and CB2 Cannabinoid Receptors Enhances the Neuroprotective Activity of a Dual CB1R/CB2R Orthosteric Agonist
Polini, Beatrice
Cervetto, Chiara
Carpi, Sara
Pelassa, Simone
Gado, Francesca
Ferrisi, Rebecca
Bertini, Simone
Nieri, Paola
Marcoli, Manuela
Manera, Clementina
LIFE-BASEL, 2020, 10 (12): : 1 - 14
[6] Vascular Dysfunction in a Transgenic Model of Alzheimer's Disease: Effects of CB1R and CB2R Cannabinoid Agonists
Navarro-Dorado, Jorge
Villalba, Nuria
Prieto, Dolores
Brera, Begona
Martin-Moreno, Ana M.
Tejerina, Teresa
de Ceballos, Maria L.
FRONTIERS IN NEUROSCIENCE, 2016, 10
[7] CB1R, CB2R and TRPV1 expression and modulation in in vivo, animal glaucoma models: A systematic review
Afflitto, Gabriele Gallo
Aiello, Francesco
Scuteri, Damiana
Bagetta, Giacinto
Nucci, Carlo
BIOMEDICINE & PHARMACOTHERAPY, 2022, 150
[8] (+)-trans-Cannabidiol-2-hydroxy pentyl is a dual CB1R antagonist/CB2R agonist that prevents diabetic nephropathy in mice
Gonzalez-Mariscal, Isabel
Carmona-Hidalgo, Beatriz
Winkler, Matthias
Unciti-Broceta, Juan D.
Escamilla, Alejandro
Gomez-Canas, Maria
Fernandez-Ruiz, Javier
Fiebich, Bernd L.
Romero-Zerbo, Silvana-Yanina
Bermudez-Silva, Francisco J.
Collado, Juan A.
Munoz, Eduardo
PHARMACOLOGICAL RESEARCH, 2021, 169
[9] Clinical Importance of Cannabinoid Type 1 Receptor (CB1R) and Cannabinoid Type 2 Receptor (CB2R) Expression in Renal Cell Carcinoma
Deligiannis, Dimitrios
Anastasiou, Ioannis
Mitropoulos, Dionysios
Mitsos, Panagiotis
Theocharis, Stamatios
CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (02)
[10] A novel near-infrared fluorescence imaging probe that preferentially binds to cannabinoid receptors CB2R over CB1R
Ling, Xiaoxi
Zhang, Shaojuan
Shao, Pin
Li, Weixia
Yang, Ling
Ding, Ying
Xu, Cong
Stella, Nephi
Bai, Mingfeng
BIOMATERIALS, 2015, 57 : 169 - 178

← 1 2 3 4 5 →